One of the most important signaling molecules for malignant B-cell proliferation, survival, and drug-resistance is the BCR whose activity is aberrantly regulated in many patients with B-cell NHLs due to multiple reasons [165]. The gene discussed is BCR; the disease is B-cell non-Hodgkin lymphoma.